摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

5-Methylfuro[2,3-d]pyrimidin-4(3H)-one | 1283372-48-4

中文名称
——
中文别名
——
英文名称
5-Methylfuro[2,3-d]pyrimidin-4(3H)-one
英文别名
5-methyl-3H-furo[2,3-d]pyrimidin-4-one
5-Methylfuro[2,3-d]pyrimidin-4(3H)-one化学式
CAS
1283372-48-4
化学式
C7H6N2O2
mdl
MFCD16992274
分子量
150.137
InChiKey
LZZBYXTYRBPCJN-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    0.5
  • 重原子数:
    11
  • 可旋转键数:
    0
  • 环数:
    2.0
  • sp3杂化的碳原子比例:
    0.142
  • 拓扑面积:
    54.6
  • 氢给体数:
    1
  • 氢受体数:
    3

上下游信息

  • 下游产品
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

  • 作为反应物:
    参考文献:
    名称:
    Discovery of novel c-Met kinase inhibitors bearing a thieno[2,3-d]pyrimidine or furo[2,3-d]pyrimidine scaffold
    摘要:
    A series of thieno[2,3-d]pyrimidines and furo[2,3-d] pyrimidines were synthesized and evaluated for the c-Met inhibition. Thieno[2,3-d]pyrimidine 6b stood out as the most potent showing an IC(50) of 35.7 nM. This compound displayed high inhibitory effect on cell proliferation in BaF3-TPR-Met cells and showed high selectivity for c-Met family against other 14 tested kinases. However, compound 6b was found ineffective in the c-Met-dependent U-87MG human gliobastoma xenograft model that may be relevant to its poor PK profile. (C) 2011 Elsevier Ltd. All rights
    DOI:
    10.1016/j.bmc.2011.05.038
  • 作为产物:
    参考文献:
    名称:
    Discovery of novel c-Met kinase inhibitors bearing a thieno[2,3-d]pyrimidine or furo[2,3-d]pyrimidine scaffold
    摘要:
    A series of thieno[2,3-d]pyrimidines and furo[2,3-d] pyrimidines were synthesized and evaluated for the c-Met inhibition. Thieno[2,3-d]pyrimidine 6b stood out as the most potent showing an IC(50) of 35.7 nM. This compound displayed high inhibitory effect on cell proliferation in BaF3-TPR-Met cells and showed high selectivity for c-Met family against other 14 tested kinases. However, compound 6b was found ineffective in the c-Met-dependent U-87MG human gliobastoma xenograft model that may be relevant to its poor PK profile. (C) 2011 Elsevier Ltd. All rights
    DOI:
    10.1016/j.bmc.2011.05.038
点击查看最新优质反应信息

文献信息

  • Discovery of novel c-Met kinase inhibitors bearing a thieno[2,3-d]pyrimidine or furo[2,3-d]pyrimidine scaffold
    作者:Ailing Zhao、Xin Gao、Yuanxiang Wang、Jing Ai、Ying Wang、Yi Chen、Meiyu Geng、Ao Zhang
    DOI:10.1016/j.bmc.2011.05.038
    日期:2011.7
    A series of thieno[2,3-d]pyrimidines and furo[2,3-d] pyrimidines were synthesized and evaluated for the c-Met inhibition. Thieno[2,3-d]pyrimidine 6b stood out as the most potent showing an IC(50) of 35.7 nM. This compound displayed high inhibitory effect on cell proliferation in BaF3-TPR-Met cells and showed high selectivity for c-Met family against other 14 tested kinases. However, compound 6b was found ineffective in the c-Met-dependent U-87MG human gliobastoma xenograft model that may be relevant to its poor PK profile. (C) 2011 Elsevier Ltd. All rights
查看更多

同类化合物

呋喃并[2,3-d]嘧啶-4(1H)-酮 呋喃并[2,3-d]嘧啶-2(3H)-酮 呋喃并[2,3-d]嘧啶 6-苯基呋喃并[2,3-D]嘧啶-4-胺 6-甲基呋喃并[2,3-d]嘧啶-4-胺 6-甲基呋喃并[2,3-d]嘧啶-4(3H)-酮 6-(4-甲氧基苯基)呋喃并[2,3-d]嘧啶-4-胺 6-(4-甲氧基苯基)-5-(3-吡啶)-呋喃并[2,3-d]嘧啶-4-胺 6-(4-甲基苯基)-呋喃并[2,3-d]嘧啶-4-胺 6-(4-溴-苯基)-4-氯-呋喃并[2,3-d]嘧啶 6-(4-氯苯基)-呋喃并[2,3-d]嘧啶-4-胺 6-(3-溴-苯基)-4-氯-呋喃并[2,3-d]嘧啶 6-(3-吡啶)-呋喃并[2,3-d]嘧啶-4-胺 5-甲基呋喃并[2,3-d]嘧啶-4-胺 5-溴呋喃并[2,3-D]嘧啶-4-胺 5-氯甲基呋喃并[2,3-d]嘧啶-2,4-二胺 5,6-二甲基呋喃[2,3-d]嘧啶-4-胺 4-氯呋喃[2,3-D]嘧啶 4-氯-6-甲基-呋喃并[2,3-d]嘧啶 4-氨基呋喃并[2,3-D]嘧啶 4,6-二甲基呋喃并[2,3-d]嘧啶 4,6-二甲基呋喃并[2,3-D]嘧啶-2-胺 3-(2-脱氧-beta-D-赤式-呋喃戊糖基)-6-甲基呋喃并[2,3-d]嘧啶-2(3H)-酮 2-甲基硫代呋喃并[2,3-d]嘧啶-6-甲醇 2,4-二氯呋喃并[2,3-d]嘧啶 2,4-二氯-5-甲基呋喃并[2,3-d]嘧啶 5,6-dimethylfuro<2,3-d>pyrimidine-4-carbonitrile 6-(3-aminophenyl)-N-[(1R)-1-phenylethyl]furo[2,3-d]pyrimidin-4-amine 6-(3-aminophenyl)-N-(3-chlorophenyl)furo[2,3-d]pyrimidin-4-amine 2-{[6-(3-aminophenyl)furo[2,3-d]pyrimidin-4-yl]amino}-4-chlorophenol 6-(3-aminophenyl)-N-(4-chloro-2-fluorophenyl)-furo[2,3-d]pyrimidin-4-amine 6-(3-aminophenyl)-N-(3,5-dichlorophenyl)furo[2,3-d]pyrimidin-4-amine 5-{[6-(3-aminophenyl)furo[2,3-d]pyrimidin-4-yl]amino}-2-methylphenol 1-(6-[4-(2-dimethylamino-ethoxy)-phenyl]-5-methyl-2-thiophene-2-yl-furo[2,3-d]pyrimidin-4-ylamino)-3-methyl-pyrrole-2,5-dione (R)-4-(4-((1-phenylethyl)amino)furo[2,3-d]pyrimidin-6-yl)benzonitrile pyrrolidine-1-carboxylic [6-(4-methoxy-phenyl)-furo[2,3-d]pyrimidin-4-yl]-amide N3-[(1-benzyl-1,2,3-triazol-4-yl)methyl]-6-(hex-1-yl)furo[2,3-d]pyrimidine-2-one N3-{[1-(4-chlorophenyl)-1,2,3-triazol-4-yl]methyl}-6-(hex-1-yl)-5-(oct-1-yn-1-yl)furo[2,3-d]pyrimidine-2-one N3-{[1-(2-fluorophenyl)-1,2,3-triazol-4-yl]methyl}-(6-hex-1-yl)furo[2,3-d]pyrimidine-2-one 6-pentyl-2,3-dihydrofuro[2,3-d]pyrimidin-2-one 2-[(5,6-di-(2-furyl)-furo[2,3-d]pyrimidin-4-yl)aminoethoxy]ethanol 6-(4-n-pentylphenyl)-2,3-dihydrofuro[2,3-d]pyrimidin-2-one 2-[(5,6-di-(2-furyl)-furo[2,3-d]pyrimidin-4-yl)amino]butan-1-ol 4-[(5,6-di-(2-furyl)-furo[2,3-d]pyrimidin-4-yl)amino]butan-1-ol 4-chloro-5,6-dimethylfuro[2,3-d]pyrimidine 3-butyl-6-(hexylsulfanylmethyl)furo[2,3-d]pyrimidin-2(3H)-one 3-dodecyl-6-(hexylsulfanylmethyl)furo[2,3-d]pyrimidin-2(3H)-one 6-(hexylsulfanylmethyl)-3-octylfuro[2,3-d]pyrimidin-2(3H)-one 3-decyl-6-(hexylsulfanylmethyl)furo[2,3-d]pyrimidin-2(3H)-one 6-decyl-2-propoxyfuro[2,3-d]pyrimidine